Overview

Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome

Status:
Completed
Trial end date:
2021-12-20
Target enrollment:
Participant gender:
Summary
This study determined the efficacy of non-hormonal therapy with citalopram compared to fluoxetine, for the treatment of menopausal symptoms in Mexican women with vasomotor syndrome (VMS) and urogenital syndrome.
Phase:
N/A
Details
Lead Sponsor:
Hospital Regional 1o de Octubre
Collaborators:
National Polytechnic Institute, Mexico
Universidad Nacional Autonoma de Mexico
Treatments:
Citalopram
Fluoxetine